Kyverna Therapeutics Ratios (2023-2026) | KYTX

Ratios Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Efficiency
Assets Average (Quarter) 232.59M376.55M351.16M321.92M282.65M243.58M206.83M240.49M275.43M
Leverage & Solvency
Interest Coverage Ratio (Quarter) -20.26-22.10-27.0513.51-16.33-2.65-4.37-13.87-49.23-20.55-2.40-11.24-1.18
Debt Ratio (Quarter) 0.080.10
Times Interest Earned (Quarter) -20.26-22.10-27.0513.51-16.33-2.65-4.37-13.87-49.23-20.55-2.40-11.24-1.18
Valuation
Enterprise Value (Quarter) -39.79M-53.43M-22.97M-57.54M-369.79M-346.24M-321.56M-285.98M-242.65M-210.30M-171.14M-279.25M-233.00M
Return Ratios
Return on Capital Employed (Quarter) -38.12%-28.45%-38.40%-49.49%-64.43%-84.22%-99.21%-83.25%-66.65%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%